CN107155304A - 开环异落叶松脂素二葡糖苷（sdg）和相关化合物用于防护辐射和化学损害的用途 - Google Patents

开环异落叶松脂素二葡糖苷（sdg）和相关化合物用于防护辐射和化学损害的用途 Download PDF

Info

Publication number
CN107155304A
CN107155304A CN201580028874.0A CN201580028874A CN107155304A CN 107155304 A CN107155304 A CN 107155304A CN 201580028874 A CN201580028874 A CN 201580028874A CN 107155304 A CN107155304 A CN 107155304A
Authority
CN
China
Prior art keywords
sdg
subject
radiation
exposed
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201580028874.0A
Other languages
English (en)
Chinese (zh)
Inventor
迈尔波·赫里斯托费多-所罗米多
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania
Original Assignee
University of Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania filed Critical University of Pennsylvania
Priority to CN202010760162.0A priority Critical patent/CN112336736A/zh
Publication of CN107155304A publication Critical patent/CN107155304A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201580028874.0A 2014-05-30 2015-06-01 开环异落叶松脂素二葡糖苷（sdg）和相关化合物用于防护辐射和化学损害的用途 Pending CN107155304A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010760162.0A CN112336736A (zh) 2014-05-30 2015-06-01 开环异落叶松脂素二葡糖苷(sdg)和相关化合物用于防护辐射和化学损害的用途

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462005330P 2014-05-30 2014-05-30
US62/005,330 2014-05-30
US201562101296P 2015-01-08 2015-01-08
US62/101,296 2015-01-08
PCT/US2015/033501 WO2015184441A2 (en) 2014-05-30 2015-06-01 USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDGs) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION AND CHEMICAL DAMAGE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202010760162.0A Division CN112336736A (zh) 2014-05-30 2015-06-01 开环异落叶松脂素二葡糖苷(sdg)和相关化合物用于防护辐射和化学损害的用途

Publications (1)

Publication Number Publication Date
CN107155304A true CN107155304A (zh) 2017-09-12

Family

ID=54700083

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201580028874.0A Pending CN107155304A (zh) 2014-05-30 2015-06-01 开环异落叶松脂素二葡糖苷（sdg）和相关化合物用于防护辐射和化学损害的用途
CN202010760162.0A Pending CN112336736A (zh) 2014-05-30 2015-06-01 开环异落叶松脂素二葡糖苷(sdg)和相关化合物用于防护辐射和化学损害的用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202010760162.0A Pending CN112336736A (zh) 2014-05-30 2015-06-01 开环异落叶松脂素二葡糖苷(sdg)和相关化合物用于防护辐射和化学损害的用途

Country Status (9)

Country Link
EP (1) EP3148560A4 (cg-RX-API-DMAC7.html)
JP (2) JP2017520620A (cg-RX-API-DMAC7.html)
KR (1) KR20170010019A (cg-RX-API-DMAC7.html)
CN (2) CN107155304A (cg-RX-API-DMAC7.html)
AU (2) AU2015266614A1 (cg-RX-API-DMAC7.html)
CA (1) CA2950744A1 (cg-RX-API-DMAC7.html)
IL (1) IL249219A0 (cg-RX-API-DMAC7.html)
MA (1) MA39899A (cg-RX-API-DMAC7.html)
WO (1) WO2015184441A2 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112601462A (zh) * 2018-08-31 2021-04-02 伊诺弗斯公司 植物抗氧化剂
CN116850162A (zh) * 2023-08-08 2023-10-10 南通大学附属医院 肠二醇在制备治疗放射性肠炎药物中的应用

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2969209T3 (es) 2016-06-07 2024-05-17 Univ Pennsylvania Composiciones y métodos para proteger órganos de lesiones por isquemia/reperfusión asociadas con el trasplante
CA3211208A1 (en) * 2017-04-03 2018-10-11 Gusto Global, Llc Rational design of microbial-based biotherapeutics
CA3077034A1 (en) * 2017-09-27 2019-04-04 The Trustees Of The University Of Pennsylvania Use of secoisolariciresinol diglucosides (sdgs) and related compounds for protection against radiation-induced cardiovascular dysfunction
US20210128596A1 (en) * 2017-09-27 2021-05-06 University Of Pennsylvania Compositions and methods for treating septic cardiomyopathy
CN121094806B (zh) * 2025-11-07 2026-02-24 深圳鼎智通讯股份有限公司 一种Android SoftPOS可信应用方法以及应用系统

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1447689A (zh) * 2000-06-14 2003-10-08 阿拉·夏皮罗 辐射保护剂
CN1814608A (zh) * 2006-03-02 2006-08-09 江南大学 一种从亚麻籽中提取纯化开环异落叶松树脂酚二葡萄糖苷的方法
CN101578042A (zh) * 2006-06-16 2009-11-11 Ip-6研究公司 预防核辐射、太阳辐射及其他辐射诱导的组织损害
US20100239696A1 (en) * 2007-05-25 2010-09-23 The Trustees Of The University Of Pennsylvania Flaxseed lignan complex, methods of using amd compositions thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2312164C (en) * 1999-06-30 2009-12-15 University Of Saskatchewan Technologies Inc. Antioxidant activity in sdg metabolites
WO2010017332A2 (en) * 2008-08-07 2010-02-11 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health & Human Services Radioprotectants targeting thrombospondin-1 and cd47
CN101759731B (zh) * 2008-12-25 2011-10-19 中国科学院兰州化学物理研究所 亚麻籽胶和开环异落叶松树脂酚二葡萄糖苷的提取方法
CA2920346A1 (en) * 2013-06-10 2014-12-18 The Trustees Of The University Of Pennsylvania Preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1447689A (zh) * 2000-06-14 2003-10-08 阿拉·夏皮罗 辐射保护剂
CN1814608A (zh) * 2006-03-02 2006-08-09 江南大学 一种从亚麻籽中提取纯化开环异落叶松树脂酚二葡萄糖苷的方法
CN101578042A (zh) * 2006-06-16 2009-11-11 Ip-6研究公司 预防核辐射、太阳辐射及其他辐射诱导的组织损害
US20100239696A1 (en) * 2007-05-25 2010-09-23 The Trustees Of The University Of Pennsylvania Flaxseed lignan complex, methods of using amd compositions thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
OM P. MISHRA，等: "Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs)", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》 *
左玉，等: "脂质的氧化及其对DNA损伤的研究进展", 《河南工业大学学报（自然科学版）》 *
杨宏志等: "开环异落叶松树脂酚二葡萄糖苷(SDG)抗氧化活性研究", 《中国食品学报》 *
郁军超，等: "机体ROS的产生及对生物大分子的", 《山东医药》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112601462A (zh) * 2018-08-31 2021-04-02 伊诺弗斯公司 植物抗氧化剂
CN112601462B (zh) * 2018-08-31 2023-10-31 伊诺弗斯公司 植物抗氧化剂
CN116850162A (zh) * 2023-08-08 2023-10-10 南通大学附属医院 肠二醇在制备治疗放射性肠炎药物中的应用

Also Published As

Publication number Publication date
JP2017520620A (ja) 2017-07-27
KR20170010019A (ko) 2017-01-25
AU2015266614A1 (en) 2016-12-15
EP3148560A2 (en) 2017-04-05
WO2015184441A9 (en) 2016-01-21
AU2020270469A1 (en) 2020-12-17
MA39899A (fr) 2021-05-26
CN112336736A (zh) 2021-02-09
EP3148560A4 (en) 2018-04-25
WO2015184441A2 (en) 2015-12-03
IL249219A0 (en) 2017-02-28
CA2950744A1 (en) 2015-12-03
JP2020121987A (ja) 2020-08-13
WO2015184441A3 (en) 2016-03-10

Similar Documents

Publication Publication Date Title
AU2020270469A1 (en) Use of secoisolariciresinol diglucosides (SDGs) and related compounds for protection against radiation and chemical damage
Gao et al. Inhibition of AIM2 inflammasome-mediated pyroptosis by Andrographolide contributes to amelioration of radiation-induced lung inflammation and fibrosis
Hasan et al. Crosstalk between ROS and autophagy in tumorigenesis: understanding the multifaceted paradox
Dai et al. Caffeic acid phenethyl ester prevents colitis-associated cancer by inhibiting NLRP3 inflammasome
Reynard et al. Drug-induced hearing loss: listening to the latest advances
Antkiewicz-Michaluk et al. Antidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat
Zhu et al. Pinocembrin inhibits the proliferation and metastasis of breast cancer via suppression of the PI3K/AKT signaling pathway
JP7612763B2 (ja) 癌治療
Xu et al. Autophagic response of intestinal epithelial cells exposed to polystyrene nanoplastics
KR20210139313A (ko) 날트렉손 및 칸나비노이드를 포함하는 암 치료
Dong et al. Discovery of a potent inhibitor of chaperone‐mediated autophagy that targets the HSC70–LAMP2A interaction in non‐small cell lung cancer cells
US10966995B2 (en) Use of secoisolariciresinol diglucosides (SDGS) and related compounds for protection against radiation and chemical damage
Champa et al. Obatoclax kills anaplastic thyroid cancer cells by inducing lysosome neutralization and necrosis
Hu et al. Kuwanon H inhibits melanoma growth through cytotoxic endoplasmic reticulum stress and impaired autophagy flux
Zheng et al. Sleep deprivation induces gut damage via ferroptosis
Pietrofesa et al. The synthetic lignan secoisolariciresinol diglucoside prevents asbestos‐induced NLRP3 inflammasome activation in murine macrophages
Sun et al. Targeting MCL1 with Sanggenon C overcomes MCL1-driven adaptive chemoresistance via dysregulation of autophagy and endoplasmic reticulum stress in cervical cancer
Yuan et al. Acetylshikonin induces apoptosis through the endoplasmic reticulum stress‐activated PERK/eIF2α/CHOP axis in oesophageal squamous cell carcinoma
Liu et al. Brusatol improves the efficacy of sorafenib in Huh7 cells via ferroptosis resistance dependent Nrf2 signaling pathway
US9155761B2 (en) Method for the treatment of cancer
Zhang et al. Baitouweng decoction regulates ferroptosis-mediated mitophagy and apoptosis through the SLC7A11/GPX4/FTH1 pathway in ulcerative colitis
US20230310359A1 (en) Anti-Oncogenic Phytochemicals and Methods and Uses for Treating Cancer
HK1240082A1 (en) Use of secoisolariciresinol diglucosides (sdgs) and related compounds for protection against radiation and chemical damage
Mukawa et al. Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium
Wu et al. Fine particulate matter exacerbates childhood asthma via DNMT3A-mediated modulation of GPX4 DNA methylation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1240082

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170912

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1240082

Country of ref document: HK